Free Trial

Streamline Health Solutions, Inc. (NASDAQ:STRM) Short Interest Update

Streamline Health Solutions logo with Medical background

Streamline Health Solutions, Inc. (NASDAQ:STRM - Get Free Report) was the target of a significant decline in short interest in October. As of October 15th, there was short interest totalling 20,700 shares, a decline of 81.0% from the September 30th total of 109,100 shares. Based on an average daily volume of 37,700 shares, the days-to-cover ratio is currently 0.5 days. Approximately 0.6% of the company's stock are short sold.

Streamline Health Solutions Stock Down 3.1 %

NASDAQ:STRM traded down $0.06 during mid-day trading on Friday, hitting $1.94. 22,334 shares of the company's stock traded hands, compared to its average volume of 15,712. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66. The company has a fifty day moving average of $4.66 and a 200 day moving average of $5.76. Streamline Health Solutions has a twelve month low of $1.92 and a twelve month high of $9.75.

Streamline Health Solutions (NASDAQ:STRM - Get Free Report) last announced its quarterly earnings data on Wednesday, September 11th. The company reported ($0.75) EPS for the quarter, missing the consensus estimate of ($0.60) by ($0.15). The company had revenue of $4.48 million during the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. StockNews.com initiated coverage on shares of Streamline Health Solutions in a report on Friday. They issued a "sell" rating on the stock. Craig Hallum raised shares of Streamline Health Solutions to a "strong-buy" rating in a report on Thursday, September 5th.

Get Our Latest Stock Analysis on Streamline Health Solutions

Streamline Health Solutions Company Profile

(Get Free Report)

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.

See Also

→ This company will win the AI race (From Porter & Company) (Ad)

Should you invest $1,000 in Streamline Health Solutions right now?

Before you consider Streamline Health Solutions, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Streamline Health Solutions wasn't on the list.

While Streamline Health Solutions currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines